4 med tech stocks with improving prognosis for 2024

Key PointsMedtech stocks have put in mixed performance over the past two years, offset by dividend payments. Many in the group are trading at value levels, with growth back in the forecast and expected to remain solid over the next two years. Tailwinds are forming that could help lift this market to new highs in 2024 and 2025. 5 stocks we like better than Johnson & JohnsonMed tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of CO ...